MPBSE board (Madhya Pradesh Board of Secondary Education) conducted Business Studies exam for Class 12th on February 18, 2026, from 9:00 AM to 12:00 PM. With 80 Marks theory structure, the questions ...

UP Board Business Studies Paper 2026: The UPMSP (Uttar Pradesh Madhyamik Shiksha Parishad) conducts the Class 12 Board Exams annually, and Business Studies is a critical subject for commerce students.

GIP obesity drug enters Phase 3 with strong cash runway, but rising competition and trial risk. Click for this VKTX update.

CBSE 12th Accountancy Exam 2026 Highlights: The Class 12 Accountancy paper was held today from 10.30 am to 1.30 pm. Follow the blog for latest updates on exam analysis, students reactions and more.

London-based Hagman Global Strategies comprehensive market study on virtual production (VP) has identified Russia as a major force in the rapidly evolving virtual production landscape, with ...

More than two centuries later, with the subsequent threats of printed books, television, calculators, and computers behind us, generative AI is the intellectual catastrophe of the moment, poised to ...

MCQs and case studies manageable, numericals slightly tricky and time-consuming; students now await unofficial answer keys for Set 2 and Set 3 ...

Statistically significant (p<0.0001) and clinically meaningful improvement in Hamilton Anxiety Rating Scale (“HAM-A”) of ~10 ...

A recent study conducted by Propulsion Québec and WSP Canada has found that the corridor between Quebec City and Toronto would be technically achievable with today’s technology to support an ...

Delivered first clinical validation of the Recursion full stack AI Operating System in FAP, demonstrating translation from AI ...

LOQTORZI® net revenue more than doubled to $40.8 million in 2025 from $19.1 million in 2024 –– Reduced secured and convertible debt by 90% from ...

Protalix BioTherapeutics, Inc. (NYSE American: PLX), a biopharmaceutical company focused on the discovery, development, production and commercialization of innovative therapeutics for rare diseases ...